{"transactions":[{"id":1042008,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:19:31.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":5.29,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114650","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114650/ownership.xml","form_type":"4"}},{"id":1042007,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:19:31.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":5.46,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114650","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114650/ownership.xml","form_type":"4"}},{"id":1042006,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:19:31.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":9.8,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000950170-25-114650","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114650/ownership.xml","form_type":"4"}},{"id":1042005,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T20:19:31.000Z","date":"2025-09-11","kind":"other","planned":false,"acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-114650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114650/ownership.xml","form_type":"4"}},{"id":1043244,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-11T17:48:14.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to this option grant shall vest and become exercisable on the day before the first anniversary of the date of grant, subject to the Reporting Person continuing to provide services to the Company through the vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.22,"expiration_date":"2034-09-25","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114308","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114308/ownership.xml","form_type":"4"}},{"id":1043243,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T17:48:14.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":true,"shares":5500,"price":1.22,"value":6710.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000950170-25-114308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114308/ownership.xml","form_type":"4"}},{"id":1398666,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-27T16:17:48.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to this option grant shall vest and become exercisable on the day before the first anniversary of the date of grant, subject to the Reporting Person continuing to provide services to the Company through the vesting date."}],"balance_after":5500,"derivative":{"exercise_price":1.22,"expiration_date":"2034-09-25","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-110019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017024110019/ownership.xml","form_type":"4"}},{"id":1431431,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-16T21:08:10.000Z","date":"2024-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":761,"price":2.58,"value":1963.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":121516,"source":{"system":"sec-edgar","filing":"0001415889-24-021476","document":"form4-08162024_090807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924021476/form4-08162024_090807.xml","form_type":"4"}},{"id":1463220,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-02T20:39:44.000Z","date":"2024-06-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1789,"price":6.03,"value":10787.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024."}],"balance_after":122277,"source":{"system":"sec-edgar","filing":"0001415889-24-018919","document":"form4-07022024_080741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924018919/form4-07022024_080741.xml","form_type":"4"}},{"id":1470754,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-24T13:00:55.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":8.5282,"value":102338.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"For purposes of the short-swing profit recovery provisions of Section 16(b) of the Securities Exchange Act of 1934, the acquisition of shares reported herein may be deemed to be matchable to the extent of 1,893 shares with the reporting person's sale of 1,893 shares of Issuer common stock to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units on December 29, 2023. The reporting person has agreed to pay to the Issuer $11,959.88, which represents the full amount of the profit realized in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4113 to $8.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":122348,"source":{"system":"sec-edgar","filing":"0001415889-24-017899","document":"form4a-06242024_010651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924017899/form4a-06242024_010651.xml","form_type":"4/A","original_submission_date":"2024-06-17"}},{"id":1477414,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-17T11:29:53.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":8.5282,"value":102338.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4113 to $8.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":122348,"source":{"system":"sec-edgar","filing":"0001415889-24-017054","document":"form4-06172024_110650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924017054/form4-06172024_110650.xml","form_type":"4"}},{"id":1638471,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-16T23:21:00.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024."}],"balance_after":80000,"derivative":{"exercise_price":15.84,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-24-004231","document":"form4-02162024_110247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004231/form4-02162024_110247.xml","form_type":"4"}},{"id":1638470,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T23:21:00.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024."}],"balance_after":110348,"source":{"system":"sec-edgar","filing":"0001415889-24-004231","document":"form4-02162024_110247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004231/form4-02162024_110247.xml","form_type":"4"}},{"id":1692946,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T21:20:10.000Z","date":"2023-12-29","kind":"sale","planned":false,"acquired":false,"shares":1893,"price":15.04,"value":28470.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 503 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023."}],"balance_after":85348,"source":{"system":"sec-edgar","filing":"0001209191-24-000366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919124000366/doc4.xml","form_type":"4"}},{"id":1822243,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-27T20:15:30.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":101000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023."}],"balance_after":101000,"derivative":{"exercise_price":5.86,"expiration_date":"2033-07-24","underlying":"Common Stock","underlying_shares":101000},"source":{"system":"sec-edgar","filing":"0001209191-23-043519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919123043519/doc4.xml","form_type":"4"}},{"id":1822242,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-27T20:15:30.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023."}],"balance_after":86738,"source":{"system":"sec-edgar","filing":"0001209191-23-043519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919123043519/doc4.xml","form_type":"4"}},{"id":1836563,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T21:00:54.000Z","date":"2023-06-30","kind":"sale","planned":false,"acquired":false,"shares":887,"price":7.34,"value":6510.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,902 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023."}],"balance_after":54738,"source":{"system":"sec-edgar","filing":"0001209191-23-041175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919123041175/doc4.xml","form_type":"4"}},{"id":1845634,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T17:31:51.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 21, 2023 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":5500,"derivative":{"exercise_price":5.29,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-23-039472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919123039472/doc4.xml","form_type":"4"}},{"id":2072780,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-04T01:34:02.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":893,"price":11.0701,"value":9885.5993,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects a reduction of 562 shares previously reported as acquired pursuant to the Issuer's employee stock purchase plan on June 30, 2022."}],"balance_after":53723,"source":{"system":"sec-edgar","filing":"0001209191-23-000475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919123000475/doc4.xml","form_type":"4"}},{"id":2190996,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-08-09T21:57:44.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022."}],"balance_after":95000,"derivative":{"exercise_price":11.47,"expiration_date":"2032-08-04","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-22-045056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919122045056/doc4.xml","form_type":"4"}},{"id":2190995,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:57:44.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,695 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022."}],"balance_after":55178,"source":{"system":"sec-edgar","filing":"0001209191-22-045056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919122045056/doc4.xml","form_type":"4"}},{"id":2228640,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T16:09:52.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 15, 2022 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":55000,"derivative":{"exercise_price":0.5463,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-22-037831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122037831/doc4.xml","form_type":"4"}},{"id":2408576,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-09T01:23:56.000Z","date":"2022-02-07","kind":"exercise","acquired":false,"shares":8363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to the option vest on April 27, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":20813,"derivative":{"exercise_price":4.81,"expiration_date":"2030-04-27","underlying":"Common Stock","underlying_shares":8363},"source":{"system":"sec-edgar","filing":"0001209191-22-007887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919122007887/doc4.xml","form_type":"4"}},{"id":2408575,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-09T01:23:56.000Z","date":"2022-02-07","kind":"exercise","acquired":false,"shares":6637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":89022,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":6637},"source":{"system":"sec-edgar","filing":"0001209191-22-007887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919122007887/doc4.xml","form_type":"4"}},{"id":2408574,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-09T01:23:56.000Z","date":"2022-02-07","kind":"exercise","acquired":true,"shares":8363,"price":4.81,"value":40226.03,"ownership":{"direct":true},"balance_after":24483,"source":{"system":"sec-edgar","filing":"0001209191-22-007887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919122007887/doc4.xml","form_type":"4"}},{"id":2408573,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-09T01:23:56.000Z","date":"2022-02-07","kind":"exercise","acquired":true,"shares":6637,"price":4.08,"value":27078.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 152 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021."}],"balance_after":16120,"source":{"system":"sec-edgar","filing":"0001209191-22-007887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919122007887/doc4.xml","form_type":"4"}},{"id":2474107,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-14T19:06:58.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in installments of one-third of the total number of shares on each anniversary of the grant date."}],"balance_after":70000,"derivative":{"exercise_price":0.98,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-21-069614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919121069614/doc4.xml","form_type":"4"}},{"id":2539448,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"exercise","acquired":false,"shares":7229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":60468,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":7229},"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2539447,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":189,"price":59.0646,"value":11163.2094,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.96 to $59.23, inclusive."}],"balance_after":9331,"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2539446,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":438,"price":58.3028,"value":25536.6264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.86 to $58.85, inclusive."}],"balance_after":9520,"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2539445,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":411,"price":57.5368,"value":23647.6248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.86 to $57.845, inclusive."}],"balance_after":9958,"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2539444,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1437,"price":56.0914,"value":80603.3418,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.73 to $56.62, inclusive."}],"balance_after":10369,"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2539443,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1903,"price":55.154,"value":104958.062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.73 to $55.70, inclusive."}],"balance_after":11806,"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2539442,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":2851,"price":54.3263,"value":154884.2813,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4."}],"balance_after":13709,"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2539441,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-19T20:28:15.000Z","date":"2021-10-18","kind":"exercise","acquired":true,"shares":7229,"price":4.08,"value":29494.32,"ownership":{"direct":true},"balance_after":16560,"source":{"system":"sec-edgar","filing":"0001209191-21-060910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121060910/doc4.xml","form_type":"4"}},{"id":2566101,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":11345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":67697,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":11345},"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566100,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-16","kind":"exercise","acquired":false,"shares":1426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":79042,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":1426},"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566099,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":1100,"price":81.19,"value":89309.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."}],"balance_after":9331,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566098,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":273,"price":80.224,"value":21901.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.05 to $80.51, inclusive."}],"balance_after":10431,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566097,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":1746,"price":79.4584,"value":138734.3664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.05 to $80.02, inclusive."}],"balance_after":10704,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566096,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":7199,"price":78.6112,"value":565922.0288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.05 to $79.045, inclusive."}],"balance_after":12450,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566095,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":1027,"price":77.8427,"value":79944.4529,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $78.045, inclusive."}],"balance_after":19649,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566094,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":11345,"price":4.08,"value":46287.6,"ownership":{"direct":true},"balance_after":20676,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566093,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":1426,"price":80.4312,"value":114694.8912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4."}],"balance_after":9331,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2566092,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-18T00:45:17.000Z","date":"2021-09-16","kind":"exercise","acquired":true,"shares":1426,"price":4.08,"value":5818.08,"ownership":{"direct":true},"balance_after":10757,"source":{"system":"sec-edgar","filing":"0001209191-21-056787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121056787/doc4.xml","form_type":"4"}},{"id":2592477,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":19370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":80468,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":19370},"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592476,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":40630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":95659,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":40630},"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592475,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":35,"price":77.5609,"value":2714.6315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.46 to $77.79, inclusive."}],"balance_after":9331,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592474,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":2616,"price":76.6628,"value":200549.8848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.31 to $77.27, inclusive."}],"balance_after":9366,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592473,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":10743,"price":75.7067,"value":813317.0781,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.31 to $76.295, inclusive."}],"balance_after":11982,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592472,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":19448,"price":75.0863,"value":1460278.3624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.31 to $75.305, inclusive."}],"balance_after":22725,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592471,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":4008,"price":73.5707,"value":294871.3656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.30 to $74.295, inclusive."}],"balance_after":42173,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592470,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":18060,"price":72.6607,"value":1312252.242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.275 to $73.265, inclusive."}],"balance_after":46181,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592469,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":3497,"price":72.0349,"value":251906.0453,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.27 to $72.265, inclusive."}],"balance_after":64241,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592468,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":1593,"price":70.8551,"value":112872.1743,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.27 to $71.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4."}],"balance_after":67738,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2592467,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-24T22:17:59.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":60000,"price":4.08,"value":244800.0,"ownership":{"direct":true},"balance_after":69331,"source":{"system":"sec-edgar","filing":"0001209191-21-053218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121053218/doc4.xml","form_type":"4"}},{"id":2598118,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-18T23:11:11.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":136289,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-052397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121052397/doc4.xml","form_type":"4"}},{"id":2598117,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T23:11:11.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":40,"price":68.62,"value":2744.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."}],"balance_after":9331,"source":{"system":"sec-edgar","filing":"0001209191-21-052397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121052397/doc4.xml","form_type":"4"}},{"id":2598116,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T23:11:11.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":2400,"price":68.3355,"value":164005.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.615 to $68.61, inclusive."}],"balance_after":9371,"source":{"system":"sec-edgar","filing":"0001209191-21-052397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121052397/doc4.xml","form_type":"4"}},{"id":2598115,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T23:11:11.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":505,"price":67.1267,"value":33898.9835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.605 to $67.60, inclusive."}],"balance_after":11771,"source":{"system":"sec-edgar","filing":"0001209191-21-052397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121052397/doc4.xml","form_type":"4"}},{"id":2598114,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T23:11:11.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":2368,"price":65.8329,"value":155892.3072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.58 to $66.55, inclusive."}],"balance_after":12276,"source":{"system":"sec-edgar","filing":"0001209191-21-052397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121052397/doc4.xml","form_type":"4"}},{"id":2598113,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T23:11:11.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":4687,"price":65.2352,"value":305757.3824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.58 to $65.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4."}],"balance_after":14644,"source":{"system":"sec-edgar","filing":"0001209191-21-052397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121052397/doc4.xml","form_type":"4"}},{"id":2598112,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-18T23:11:11.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":10000,"price":4.08,"value":40800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 203 shares acquired under the Issuer's employee stock purchase plan on June 30, 2021."}],"balance_after":19331,"source":{"system":"sec-edgar","filing":"0001209191-21-052397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121052397/doc4.xml","form_type":"4"}},{"id":2617987,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-03T21:12:32.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on August 30, 2021."}],"balance_after":100000,"derivative":{"exercise_price":58.56,"expiration_date":"2031-07-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-049398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121049398/doc4.xml","form_type":"4"}},{"id":2890547,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-29T21:15:09.000Z","date":"2021-01-28","kind":"exercise","acquired":false,"shares":6128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":146289,"derivative":{"exercise_price":4.08,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":6128},"source":{"system":"sec-edgar","filing":"0000899243-21-003728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000089924321003728/doc4.xml","form_type":"4"}},{"id":2890546,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-29T21:15:09.000Z","date":"2021-01-28","kind":"exercise","acquired":true,"shares":6128,"price":4.08,"value":25002.24,"ownership":{"direct":true},"balance_after":9128,"source":{"system":"sec-edgar","filing":"0000899243-21-003728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000089924321003728/doc4.xml","form_type":"4"}},{"id":3078869,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-21T23:57:49.000Z","date":"2020-07-21","kind":"purchase","acquired":true,"shares":3000,"price":19,"value":57000.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000899243-20-019908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000089924320019908/doc4.xml","form_type":"4"}},{"id":3080671,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-07-17T23:02:47.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":88137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on August 16, 2020."}],"balance_after":88137,"derivative":{"exercise_price":19,"expiration_date":"2030-07-16","underlying":"Common Stock","underlying_shares":88137},"source":{"system":"sec-edgar","filing":"0000899243-20-019575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000089924320019575/doc4.xml","form_type":"4"}},{"id":3555356,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-16T21:16:40.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":641025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of shares included in the original April 1, 2019 Form 4 filing was incorrect and the Company is filing this amendment to correct the number of shares in the award grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient."}],"balance_after":641025,"derivative":{"exercise_price":3.72,"expiration_date":"2029-03-28","underlying":"Common stock","underlying_shares":641025},"source":{"system":"sec-edgar","filing":"0000882104-19-000039","document":"wf-form4a_155544938547289.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000039/wf-form4a_155544938547289.xml","form_type":"4/A","original_submission_date":"2019-04-01"}},{"id":3572976,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-01T21:12:15.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":628930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient."}],"balance_after":628930,"derivative":{"exercise_price":3.72,"expiration_date":"2029-03-28","underlying":"Common stock","underlying_shares":628930},"source":{"system":"sec-edgar","filing":"0000882104-19-000025","document":"wf-form4_155415312035896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000025/wf-form4_155415312035896.xml","form_type":"4"}},{"id":3717100,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2018-12-28T23:30:10.000Z","date":"2018-12-27","kind":"disposition_to_issuer","acquired":false,"shares":226442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock due to performance criteria not being achieved under equity incentive plans."}],"balance_after":225029,"source":{"system":"sec-edgar","filing":"0000882104-18-000130","document":"wf-form4_154603979367450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000130/wf-form4_154603979367450.xml","form_type":"4"}},{"id":3717099,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2018-12-28T23:30:10.000Z","date":"2018-12-27","kind":"tax_withholding","acquired":false,"shares":3553,"price":3.02,"value":10730.06,"ownership":{"direct":true},"balance_after":451471,"source":{"system":"sec-edgar","filing":"0000882104-18-000130","document":"wf-form4_154603979367450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000130/wf-form4_154603979367450.xml","form_type":"4"}},{"id":3806870,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-27T20:40:44.000Z","date":"2018-09-25","kind":"grant","acquired":true,"shares":339678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on a monthly basis pro rata over the 48 months following January 1, 2018, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient."}],"balance_after":339678,"derivative":{"exercise_price":2.52,"expiration_date":"2028-09-25","underlying":"Common stock","underlying_shares":339678},"source":{"system":"sec-edgar","filing":"0000882104-18-000103","document":"wf-form4_153808082735831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000103/wf-form4_153808082735831.xml","form_type":"4"}},{"id":3897542,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-12T20:31:15.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":694900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The stock options were approved by the compensation committee of the issuer's board of directors effective August 29, 2017, subject to stockholder approval of an amendment to the issuer's equity plan pursuant to which the stock option was granted.  The issuer's stockholders approved the amendment on June 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on August 28, 2018; (b) 25% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following August 28, 2018; (c) 25% of the shares subject to the option shall vest upon the price of the Company's Common Stock closing above $3.91 for twenty (20) consecutive trading days; and (d) 25% of the shares subject to the option shall vest upon the price of the Company's Common Stock closing above $4.41 for twenty (20) consecutive trading days, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employement provided in the severance agreement between the issuer and the recipient."}],"balance_after":694900,"derivative":{"exercise_price":2.94,"expiration_date":"2027-08-28","underlying":"Common stock","underlying_shares":694900},"source":{"system":"sec-edgar","filing":"0000882104-18-000070","document":"wf-form4_152883545770159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000070/wf-form4_152883545770159.xml","form_type":"4"}},{"id":4127373,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2017-12-20T01:04:26.000Z","date":"2017-12-15","kind":"disposition_to_issuer","acquired":false,"shares":17818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock due to performance criteria not being achieved under equity incentive plans."}],"balance_after":455024,"source":{"system":"sec-edgar","filing":"0000882104-17-000127","document":"wf-form4_151373185271780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000127/wf-form4_151373185271780.xml","form_type":"4"}},{"id":4371957,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2017-03-27T21:51:04.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":5000,"price":1.978,"value":9890.0,"ownership":{"direct":true},"balance_after":472842,"source":{"system":"sec-edgar","filing":"0000882104-17-000033","document":"wf-form4_149065144943990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000033/wf-form4_149065144943990.xml","form_type":"4"}},{"id":4371956,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2017-03-27T21:51:04.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":5000,"price":1.9768,"value":9884.0,"ownership":{"direct":true},"balance_after":467842,"source":{"system":"sec-edgar","filing":"0000882104-17-000033","document":"wf-form4_149065144943990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000033/wf-form4_149065144943990.xml","form_type":"4"}},{"id":4371955,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2017-03-27T21:51:04.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":10000,"price":1.9757,"value":19757.0,"ownership":{"direct":true},"balance_after":462842,"source":{"system":"sec-edgar","filing":"0000882104-17-000033","document":"wf-form4_149065144943990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000033/wf-form4_149065144943990.xml","form_type":"4"}},{"id":4371954,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2017-03-27T21:51:04.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":350,"price":1.975,"value":691.25,"ownership":{"direct":true},"balance_after":452842,"source":{"system":"sec-edgar","filing":"0000882104-17-000033","document":"wf-form4_149065144943990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000033/wf-form4_149065144943990.xml","form_type":"4"}},{"id":4371953,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2017-03-27T21:51:04.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":4650,"price":1.974,"value":9179.1,"ownership":{"direct":true},"balance_after":452492,"source":{"system":"sec-edgar","filing":"0000882104-17-000033","document":"wf-form4_149065144943990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000033/wf-form4_149065144943990.xml","form_type":"4"}},{"id":4398791,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2017-03-08T01:19:16.000Z","date":"2017-03-04","kind":"grant","acquired":true,"shares":212669,"price":2.04,"value":433844.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2018; 16.66% on December 2019; 16.66% on December 2020; and 16.66% on December 2021."}],"balance_after":447842,"source":{"system":"sec-edgar","filing":"0000882104-17-000023","document":"wf-form4_148893594300931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000023/wf-form4_148893594300931.xml","form_type":"4"}},{"id":4521171,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, CFO"}}],"security":"Common stock","published_at":"2016-12-15T21:17:34.000Z","date":"2016-12-13","kind":"disposition_to_issuer","acquired":false,"shares":1919,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":235173,"source":{"system":"sec-edgar","filing":"0000882104-16-000251","document":"wf-form4_148183663161418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210416000251/wf-form4_148183663161418.xml","form_type":"4"}}]}